4.6 Article

Treatment of suicidal people around the world

Journal

BRITISH JOURNAL OF PSYCHIATRY
Volume 199, Issue 1, Pages 64-70

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1192/bjp.bp.110.084129

Keywords

-

Categories

Funding

  1. Bristol-Myers Squibb
  2. Eli Lilly
  3. GlaxoSmithKline
  4. Johnson & Johnson Pharmaceuticals
  5. Ortho-McNeil Pharmaceuticals
  6. Pfizer
  7. Sanofi-Aventis
  8. US National Institute of Mental Health (NIMH) [R01-MH070884, MH077883]
  9. John D. and Catherine T. MacArthur Foundation
  10. Pfizer Foundation
  11. US Public Health Service [R13-MH066849, R01-MH069864, R01-DA016558]
  12. Fogarty International Center [FIRCA R03-TW006481]
  13. Pan American Health Organization
  14. Eli Lilly Co.
  15. Ortho-McNeil Pharmaceutical
  16. Australian National Health and Medical Research Council
  17. State of Sao Paulo Research Foundation (FAPESP) [03/00204-3]
  18. Ministry of Health
  19. National Centre for Public Health Protection
  20. Shenzhen Bureau of Health
  21. Shenzhen Bureau of Science, Technology and Information
  22. Ministry of Social Protection
  23. European Commission [QLG5-1999-01042, 2004123]
  24. Piedmont Region (Italy)
  25. Fondo de Investigacion Sanitaria
  26. Instituto de Salud Carlos III, Spain [FIS 00/0028]
  27. Ministerio de Ciencia y Tecnologia, Spain [SAP 2000-158-CE]
  28. Departament de Salut
  29. Generalitat de Catalunya, Spain
  30. Instituto de Salud Carlos III [GIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]
  31. WHO (India)
  32. United Nations Development Group Iraq Trust
  33. Israel National Institute for Health Policy and Health Services Research
  34. National Insurance Institute of Israel
  35. Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
  36. Lebanese Ministry of Public Health
  37. WHO (Lebanon)
  38. Fogarty International
  39. Janssen Cilag
  40. Roche
  41. Novartis
  42. National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
  43. National Council on Science and Technology [CONACyT-G30544-H]
  44. New Zealand Ministry of Health
  45. Alcohol Advisory Council
  46. Health Research Council
  47. WHO (Geneva)
  48. WHO (Nigeria)
  49. Federal Ministry of Health
  50. Abuja
  51. Nigeria
  52. Ministry of Public Health (formerly ministry of Health)
  53. US National Institute of Mental Health [R01-MH059575]
  54. National Institute of Drug Abuse
  55. South African Department of Health
  56. University of Michigan
  57. NIMH [R01-MH61905, U01-MH60220]
  58. Robert wood Johnson Foundation (RWJF) [044708]
  59. John W. Alden Trust
  60. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [03/00204-3] Funding Source: FAPESP

Ask authors/readers for more resources

Background Suicide is a leading cause of death worldwide; however, little information is available about the treatment of suicidal people, or about barriers to treatment. Aims To examine the receipt of mental health treatment and barriers to care among suicidal people around the world. Method Twenty-one nationally representative samples worldwide (n=55 302; age 18 years and over) from the World Health Organization's World Mental Health Surveys were interviewed regarding past-year suicidal behaviour and past-year healthcare use. Suicidal respondents who had not used services in the past year were asked why they had not sought care. Results Two-fifths of the suicidal respondents had received treatment (from 17% in low-income countries to 56% in high-income countries), mostly from a general medical practitioner (22%), psychiatrist (15%) or non-psychiatrist (15%). Those who had actually attempted suicide were more likely to receive care. Low perceived need was the most important reason for not seeking help (58%), followed by attitudinal barriers such as the wish to handle the problem alone (40%) and structural barriers such as financial concerns (15%). Only 7% of respondents endorsed stigma as a reason for not seeking treatment. Conclusions Most people with suicide ideation, plans and attempts receive no treatment. This is a consistent and pervasive finding, especially in low-income countries. Improving the receipt of treatment worldwide will have to take into account culture-specific factors that may influence the process of help-seeking.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available